93 related articles for article (PubMed ID: 11070391)
1. Vertebral artery dissection and hyperhomocysteinemia: a case report.
Caso V; Cardaioli G; Gallai V; Parnetti L
Cerebrovasc Dis; 2000; 10 Suppl 4():9-11. PubMed ID: 11070391
[No Abstract] [Full Text] [Related]
2. Spontaneous cervical artery dissection: from risk factors toward pathogenesis.
Brandt T; Grond-Ginsbach C
Stroke; 2002 Mar; 33(3):657-8. PubMed ID: 11872881
[No Abstract] [Full Text] [Related]
3. Mutated 5,10-methylenetetrahydrofolate reductase, hyperhomocysteinemia and risk for cardiovascular disease. Nature, nurture or nonsense?
Blom HJ
Eur J Clin Invest; 2001 Jan; 31(1):6-8. PubMed ID: 11168432
[No Abstract] [Full Text] [Related]
4. The T allele of the C(677)T 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism may protect endothelial function in young, normal subjects.
Butler R; Morris AD; Struthers AD
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):193-4. PubMed ID: 11788482
[No Abstract] [Full Text] [Related]
5. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece.
Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tzolou A; Kolaitis N; Vartholomatos G
Int Angiol; 2002 Sep; 21(3):268-71. PubMed ID: 12384649
[TBL] [Abstract][Full Text] [Related]
6. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection.
Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E
Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690
[TBL] [Abstract][Full Text] [Related]
7. Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients.
Hagen W; Födinger M; Heinz G; Buchmayer H; Hörl WH; Sunder-Plassmann G
Kidney Int Suppl; 2001 Feb; 78():S253-7. PubMed ID: 11169021
[TBL] [Abstract][Full Text] [Related]
8. Homozygous C677T mutation of the 5,10 methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in Italian patients with a history of early-onset ischemic stroke.
Soriente L; Coppola A; Madonna P; Cerbone AM; Di Minno G; Orefice G; D'Angelo A
Stroke; 1998 Apr; 29(4):869-71. PubMed ID: 9550528
[No Abstract] [Full Text] [Related]
9. Hyperhomocysteinemia and left atrial thrombus in a stroke patient with sinus rhythm.
Cupini LM; De Simone R
Stroke; 2003 Sep; 34(9):e143-5; author reply e143-5. PubMed ID: 12933972
[No Abstract] [Full Text] [Related]
10. [Molecular genetics of the remethylation of homocysteine].
Chango A; Parrot-Roulaud F; Nicolas J
Ann Biol Clin (Paris); 1999; 57(1):37-42. PubMed ID: 9920965
[TBL] [Abstract][Full Text] [Related]
11. Why should mild hyperhomocysteinemia be responsible for CAD?
Caso V; Gallai V
Stroke; 2003 Nov; 34(11):e209. PubMed ID: 14563957
[No Abstract] [Full Text] [Related]
12. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency.
Selzer RR; Rosenblatt DS; Laxova R; Hogan K
N Engl J Med; 2003 Jul; 349(1):45-50. PubMed ID: 12840091
[No Abstract] [Full Text] [Related]
13. Hyperhomocysteinemia and hyperlipidemia in coronary heart disease.
Gao W; Jiang N; Meng Z; Tang J
Chin Med J (Engl); 1999 Jul; 112(7):586-9. PubMed ID: 11601248
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary thromboembolism due to severe hyperhomocysteinemia associated with a methyltetrahydrofolate reductase mutation.
Cho KH; Jeong MH; Sim DS; Hong YJ; Kim JH; Ahn Y; Kang JC
Korean J Intern Med; 2013 Jan; 28(1):112-5. PubMed ID: 23346007
[No Abstract] [Full Text] [Related]
15. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.
Pathare A; al Kindi S; al Belushi T; Bayoumi R; Dennison D; Murlitharan S
Haematologia (Budap); 2002; 32(4):551-6. PubMed ID: 12803132
[TBL] [Abstract][Full Text] [Related]
16. Case records of the Massachusetts General Hospital. Case 27-2014. A 10-month-old boy with microcephaly and episodic cyanosis.
Sahai I; Mochida GH; Grabowski EF; Caruso PA
N Engl J Med; 2014 Aug; 371(9):847-58. PubMed ID: 25162892
[No Abstract] [Full Text] [Related]
17. Hyperhomocysteinemia: another independent vascular risk factor.
Deleu D
Saudi Med J; 2000 Aug; 21(8):787-8. PubMed ID: 11423902
[No Abstract] [Full Text] [Related]
18. Frequent polymorphism of the human methylenetetrahydrofolate reductase.
Linnebank M; Homberger A; Koch HG; Bova I; Sylantiev C; Bornstein NM; Chapman J; Korczyn AD
Stroke; 2000 Apr; 31(4):990. PubMed ID: 10754661
[No Abstract] [Full Text] [Related]
19. Methylenetetrahydrofolate reductase and neural tube defects.
Papapetrou C; Lynch SA; Burn J; Edwards YH
Lancet; 1996 Jul; 348(9019):58. PubMed ID: 8691945
[No Abstract] [Full Text] [Related]
20. Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium.
Mitchell LE
Am J Hum Genet; 1997 Apr; 60(4):1006-7. PubMed ID: 9106551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
